Speaker Profile

___	__
	Biography Dr. Nasello has been practicing Obstetrics & Gynecology for almost 30 years. She is a Generalist OB-GYN with a special interest in MIGS & Menopause. She retired from hospital work in 2018, & has represented Ontario's OB-GYNs as Chair, OMA Section on Obstetrics & Gynaecology & President of the Ontario Society of Obstetricians & Gynaecologists since then. She is a member of OMA Women, and has a special interest in gender bias in medicine, and in the Gender Pay Gap in surgery. Dr. Nasello has run a successful Advocacy campaign for Ontario's Obstetricians & Gynaecologists in 2020, and spokesperson on behalf of OSOG for Covid-19 vaccines in Pregnancy & lactation. She is also co-chair of the SOGC Ontario CME as president of the host society. Disclosure 1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: a) Direct financial payments including receipt of honoraria: OMA b) Membership on advisory boards or speakers’ bureaus: Lupin 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Dr. Nasello has been practicing Obstetrics & Gynecology for almost 30 years. She is a Generalist OB-GYN with a special interest in MIGS & Menopause. She retired from hospital work in 2018, & has represented Ontario's OB-GYNs as Chair, OMA Section on Obstetrics & Gynaecology & President of the Ontario Society of Obstetricians & Gynaecologists since then. She is a member of OMA Women, and has a special interest in gender bias in medicine, and in the Gender Pay Gap in surgery. Dr. Nasello has run a successful Advocacy campaign for Ontario's Obstetricians & Gynaecologists in 2020, and spokesperson on behalf of OSOG for Covid-19 vaccines in Pregnancy & lactation. She is also co-chair of the SOGC Ontario CME as president of the host society.
Disclosure
1. I have a relationship with a for-profit and/or a not-for-profit organization to disclose: a) Direct financial payments including receipt of honoraria: OMA b) Membership on advisory boards or speakers’ bureaus: Lupin 2. I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).